One-Day IV Ketamine Treatment for Fibromyalgia with Long-Term Follow-Up in a Large Patient Group

Approximately 2% of the population is affected by fibromyalgia, a complex chronic neurosensory disorder.

• Ketamine may reduce pain associated with fibromyalgia, as indicated by previous small studies and case reports.
• Prior studies involved limited participant numbers, ranging from 11 to 34 individuals.
• There is a lack of data on the effects of repeated ketamine infusions over extended periods for fibromyalgia.

Simplified